1) ~(125)I radioactive seeds
125I种子
1.
Objective To investigate the therapeutic efficacy of ~(125)I radioactive seeds interstitial implantation for late malignancies.
方法:125I种子源作为近距离放疗植入于难以根除性切除的各项恶性肿瘤(肝、胰、前列腺等)共35例,随访其治疗效果。
2) 125I seed source
125I种子源
1.
The dose field distribution of 125I seed source is measured by the method of slowly sensitive film,ionized chamber and Monte Carlo simulation respectively.
采用慢感光胶片法、电离室法和蒙特卡洛模拟方法测定了新研制的6711型125I种子源的剂量场分布。
3) 125I seeds source
125I种籽源
1.
It is necessary to search for the proper ionizing radiation protecting method on operating 125I seeds source interstitial implantation.
为探讨操作125I种籽源应采取适当防护措施的必要性,阐述了125I种籽源植入手术各阶段的电离辐射监测结果,并对无防护条件下手术医生可能受到的辐射剂量做出估算:对于总活度为925 MBq的40粒种籽源,在开源、核对及装源入植源器操作时,操作距离30 cm,操作时间10 min,则操作者受照剂量为70μSv;对于手术医生,从辐射防护角度进行估计,一例手术,包括插植和带源缝合操作,医生在其操作位置的受照剂量可达184μSv。
4) 125I seeds
125I粒子
1.
15 patients were placed the ordinary domestic stents in group A and 14 patients were taken in the intraluminal irradiation stents of 125I seeds source in group B.
方法29例中晚期食管癌患者分为两组,A组15例应用普通食管支架治疗,B组14例应用带有125I粒子的放射性食管支架进行治疗。
2.
Objective To investigate the feasibility and short-term efficacy of CT-guided interstitial implantation of 125I seeds for lung cancer.
目的探讨CT引导下放射性125I粒子组织间植入治疗肺癌的技术可行性和近期疗效。
3.
Objective To investigate the effect of treatment of recurrent brain gliorvas by microsurgical excision combined with 125I seeds.
目的研究12例复发性脑胶质瘤显微手术切除加125I粒子置入治疗复发性脑胶质瘤的近期治疗效果。
5) 125I seed
125I粒子
1.
Objective: To introduce the method of CT-guided 125I seed interstitial implantation in treatment of malignant tumor and evaluate the clinical value.
目的:介绍CT导向下125I粒子组织间插植治疗恶性肿瘤的技术方法并评价其临床价值。
2.
Objective To evaluate the short-term efficacy of interstitial implantation of 125I seeds by using flexible fiberoptic bronchoscope (FFB) guided by CT for advanced non-small cell lung cancer (NSCLC).
目的探讨CT引导下经皮穿刺和纤维支气管镜(flexible fiberoptic bronchoscope,FFB)直视下种植放射性125I粒子植入近距离内照射治疗晚期非小细胞肺癌(non-small cell lung cancer,NSCLC)的近期效果。
3.
Methods: 75 patients of NSCLC were divided into 3 groups,A group received Cisplatin Sustained Release for Implant with 125I seed;B group received Cisplatin Sustained Release seed;C group received NVB+DDP(NP)regimen chemotherapy.
目的:探讨CT引导下经皮穿刺种植植入用缓释顺铂粒子联合放射性125I粒子治疗晚期非小细胞肺癌(NSCLC)的短期疗效。
6) Iodine-125 seeds
125I粒子
1.
Objective To explore the feasibility and primary of metallic self-expanding stent combine with Iodine-125 seeds in treatment of malignant esophageal obstruction.
目的探讨125I粒子与内支架结合治疗食管恶性狭窄的可行性及相关疗效。
2.
Objective To make an estimate of clinical practice of iodine-125 seeds interstitial brachytherapy guided by nasal endoscopy for the residue of nasopharyngeal carcinoma after radiotherapy.
目的对放疗后鼻咽部仍有残留病灶的鼻咽癌患者行鼻内镜引导下放射性125I粒子植入术的临床应用进行评估。
补充资料：种子生现行现行薰种子
【种子生现行现行薰种子】
（术语）在色者二缘和合，在心者四缘和合时，阿赖耶识所持之种子，生现行。是本有种子生果之功能也。此谓之种子生现行。其现行之法，必随所应而薰种子，其薰之种子，即新薰种子也。此谓之现行薰种子。应知此时有三法，成二重之因果。三法者：一为能生之种子，二为所生之现行，三为所薰之种子。二重之因果者：一为种子生现行，二为现行薰种子。此三法同时成二重之因果。以所生之现行，即薰种子故也。此谓之种子生现行现行薰种子。又曰三法展转因果同时。就八识而论，则第八识所持之种子为因，生眼等之七转识，同时七转识之现行法为因，生第八识之种子。因而谓之七转第八互为因果。本宗因果之谈于此为极。
（术语）在色者二缘和合，在心者四缘和合时，阿赖耶识所持之种子，生现行。是本有种子生果之功能也。此谓之种子生现行。其现行之法，必随所应而薰种子，其薰之种子，即新薰种子也。此谓之现行薰种子。应知此时有三法，成二重之因果。三法者：一为能生之种子，二为所生之现行，三为所薰之种子。二重之因果者：一为种子生现行，二为现行薰种子。此三法同时成二重之因果。以所生之现行，即薰种子故也。此谓之种子生现行现行薰种子。又曰三法展转因果同时。就八识而论，则第八识所持之种子为因，生眼等之七转识，同时七转识之现行法为因，生第八识之种子。因而谓之七转第八互为因果。本宗因果之谈于此为极。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条